By Emma Nesper | Communications Specialist
We are pleased to report that our efforts to create access to misoprostol tablets to manage bleeding after childbirth have yielded a broad base of support in Ethiopia, including from the government and partners working towards safer motherhood for Ethiopian mothers. Following a gathering we organized in January 2010 where health care providers and program partners shared successful results and encouraging stories about the use of misoprostol by health workers who care for pregnant mothers, Ethiopia's Ministry of Health took the lead in scaling up training of community health workers and access to the simple tablets, especially to benefit the many women who labor at home.
In a clear demonstration of this support for misoprostol as a strategy for reducing bleeding-related maternal deaths, this month, June 2010, the Ethiopian drug authority took the important policy step of registering misoprostol, thereby enabling legal importation, marketing and distribution of the tablets throughout Ethiopia and paving the way to access for millions of women.
With the generous support of donors and committed maternal health advocates, we continue to collaborate with our local partners in Ethiopia to educate community health workers and make misoprostol tablets available to the women who need them the most.
Links:
By Emma Nesper | Communications Specialist
By Emma Nesper | Communications Specialist
Project reports on GlobalGiving are posted directly to globalgiving.org by Project Leaders as they are completed, generally every 3-4 months. To protect the integrity of these documents, GlobalGiving does not alter them; therefore you may find some language or formatting issues.
If you donate to this project or have donated to this project, you can receive an email when this project posts a report. You can also subscribe for reports without donating.